Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
PHARMABIZ.com Examines India’s Push For Clearer Definition Of Counterfeit, Substandard Medicines

“India has taken the lead to get together a number of generic drug-producing nations to call for better definitions to ensure quality, strengthening of regulatory authorities in the respective countries, and bringing focus of the world to public health instead of intellectual property,” PHARMABIZ.com writes in an article that examines the recent meeting of leaders from Brazil, India and South Africa on issues regarding counterfeit medicines. “The initiative came as an inter-governmental working group, appointed by the World Health Assembly last year, is looking at the WHO’s role to ensure the availability of quality, safe and efficacious and affordable medicine,” according to the new service.

Also In Global Health News: Disasters In Indonesia; Maternal Health In Pakistan; Gates Grand Challenges Grants; Development Innovation Ventures; Dengue Fever Treatment

Death Toll Rises From Two Disasters In Indonesia; Minister Says Aid Not Needed Yet The death toll from two recent disasters in Indonesia – a tsunami and volcano eruption – “rose to more than 340 Thursday” and hundreds were reportedly missing, the Associated Press reports. According to an official, “a warning system installed…

Cholera Epidemic In Haiti Persists Despite Slowdown In Fatalities

“A multinational medical response has slowed deaths in a Haitian cholera epidemic that has killed more than 250 people so far, but the outbreak is likely to widen, a senior U.N. official said on Sunday,” Reuters reports. The U.N., Haitian government and aid partners “have launched a major effort to try to contain the epidemic” of more than 3,000 cases in the country so far (Delva, 10/25). The New York Times reports that the death rate, according to the Haitian government, has “declined – from 10.6 percent of known cases three days earlier to 8.2 percent now.”

PhRMA Representatives Meet With Officials In India To Discuss Compulsory Licensing

During a visit with government officials, industry leaders and NGOs in India last week, representatives from Pharmaceutical Research and Manufacturers of America (PhRMA), a U.S. lobbying group that represents the country’s pharmaceutical industry and biotechnology companies, addressed “the Indian government’s proposal to allow local drugmakers to make low-cost version of patented drugs so that they can be made available to patients,” the Economic Times reports. “Issuing compulsory licensing is not a long-term solution and will be counterproductive,” PhRMA Executive VP Christopher Singer said.

Also In Global Health News: Foreign Aid In Ethiopia; Elizabeth Glaser Pediatric AIDS Foundation; Health In Myanmar; Poverty In Zambia; Rwanda’s Progress on MDGs; Men Involved In PMTCT Of HIV

Ethiopian Government Restricting Opponents’ Access To Development Aid, Report Says Ethiopia’s government has been restricting access to food and other types of foreign aid among opposition supporters, Human Rights Watch (HRW) said in a report on Tuesday, Reuters reports (Malone, 10/19). The report is based on more than 200 interviews, conducted over…

Financing HIV/AIDS Prevention, Treatment Could Cost $400B-$700B Over 20 Years

A new report published by the Results for Development Institute in the Lancet “has offered governments and donors a glimpse into the future of HIV epidemics – and what it will cost to prevent and treat them. Researchers warn of hard choices ahead and a need for some countries to take more responsibility for their national programmes, IRIN/PlusNews reports. Study authors present their “cheapest” and “ideal” scenarios for HIV funding in the future, according to IRIN/PlusNews.